*EMBARGOED All research presented at the 2022 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Sunday, October 23, 2022, at 12:00 pm EDT.
Tuesday, October 25, 2022 | 10:00 AM – 12:00 PM ET | Location: Crown Ballroom
Author Insight from Wissam Ghusn, MD, Mayo Clinic
What’s new here and important for clinicians?
Our data show that patients with inflammatory bowel disease (IBD) who identify as LGBTQ+ are at increased risk in several aspects of social determinants of health that can ultimately impact the outcome of their IBD. We believe that efforts should focus on better understanding healthcare disparities in the LGBTQ+ community in order to improve their care and address their needs. Clinicians should be mindful to address patients’ sexual orientation and gender identity, when appropriate, during the clinic visit and address how it impacts their IBD.
What do patients need to know?
Patients who identify as LGBTQ+ have the right to equal access to healthcare without stigma or discrimination. Any type of discrimination should not be tolerated, and everyone in the medical field can play a role in addressing and minimizing health disparities in the LGBTQ+ community. We recognize that the impact of having a chronic condition, like IBD, and dealing with one’s sexual orientation and gender identity can have long term effects on an individual’s disease outcomes, wellbeing, and mental health. Our goal is to achieve healthcare equality for all individuals.
Read the Abstract
Wissam Ghusn, MD & Victor Chedid, MD, MS, Mayo Clinic
Ghusn.wissam [at] mayo.edu
Media Interview Requests
To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi.org or by phone at 301-263-9000.